Financial Ratios NetraMark Holdings Inc. OTC Markets

Stocks

AINMF

CA64119M1059

Software

Market Closed - OTC Markets Other stock markets 14:25:14 2026-07-06 EDT			5-day change	1st Jan Change
0.5614 ^USD	+22.05%		+39.90%	-29.40%

06-29	NetraMark to Perform AI-Assisted Analysis of Clinical Trial Data For Biopharm Company	MT
06-29	NetraMark Holdings Inc. Signs NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company	CI

25877908cb.Ka3LqJt2CyRgAb1jsyGK433Sb_sDSQyIZrLrSXqhy04.eN-f4O4lUXcsW94uwBnGlSqBIpdiDT77F_GuJEnQiTRDxPzM0wxyQRA5zg

Published financial data: NETRAMARK HOLDINGS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	-	113K	89.27K	456K	432K
Total Revenues	-	113K	89.27K	456K	432K
Gross Profit	-	113K	89.27K	456K	432K
Selling General & Admin Expenses, Total	3.84M	5.67M	4.02M	3.33M	4.88M
Stock-Based Compensation (IS)	1.21M	1.25M	1.43M	596K	820K
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	-	597K	610K	-	-
Other Operating Expenses, Total	5.05M	7.51M	6.06M	3.93M	5.7M
Operating Income	-5.05M	-7.4M	-5.97M	-3.47M	-5.26M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-37.95K	-	110K	140K	41.7K
EBT, Excl. Unusual Items	-5.08M	-7.4M	-5.86M	-3.33M	-5.22M
Merger & Related Restructuring Charges	-	-534K	-	-	-
Impairment of Goodwill	-	-4.03M	-6.41M	-	-
Asset Writedown	-	-1.73M	-1.91M	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-5.08M	-13.7M	-14.17M	-3.33M	-5.22M
Income Tax Expense	-	-248K	-	-	-
Earnings From Continuing Operations	-5.08M	-13.45M	-14.17M	-3.33M	-5.22M
Net Income to Company	-5.08M	-13.45M	-14.17M	-3.33M	-5.22M
Net Income - (IS)	-5.08M	-13.45M	-14.17M	-3.33M	-5.22M
Net Income to Common Incl Extra Items	-5.08M	-13.45M	-14.17M	-3.33M	-5.22M
Net Income to Common Excl. Extra Items	-5.08M	-13.45M	-14.17M	-3.33M	-5.22M
Per Share Items
Net EPS - Basic	-0.2	-0.33	-0.29	-0.05	-0.07
Basic EPS - Continuing Operations	-0.2	-0.33	-0.29	-0.05	-0.07
Basic Weighted Average Shares Outstanding	25.76M	40.55M	49.67M	67.43M	78.73M
Net EPS - Diluted	-0.2	-0.33	-0.29	-0.05	-0.07
Diluted EPS - Continuing Operations	-0.2	-0.33	-0.29	-0.05	-0.07
Diluted Weighted Average Shares Outstanding	25.76M	40.55M	49.67M	67.43M	78.73M
Normalized Basic EPS	-0.12	-0.11	-0.07	-0.03	-0.04
Normalized Diluted EPS	-0.12	-0.11	-0.07	-0.03	-0.04
Supplemental Items
EBITDA	-	-6.8M	-5.36M	-	-
EBITA	-5.05M	-7.4M	-5.97M	-3.47M	-5.26M
EBIT	-5.05M	-7.4M	-5.97M	-3.47M	-5.26M
Total Revenues (As Reported)	-	113K	89.27K	456K	432K
Effective Tax Rate - (Ratio)	-	1.81	-	-	-
Total Deferred Taxes	-	-248K	-	-	-
Normalized Net Income	-3.18M	-4.62M	-3.66M	-2.08M	-3.26M
Supplemental Operating Expense Items
Advertising Expense	-	1.18M	503K	60.54K	263K
Selling and Marketing Expenses	-	1.18M	503K	60.54K	263K
Research And Development Expense From Footnotes	-	-	610K	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	609K	1.12M	879K	671K
Stock-Based Comp., Other (Total)	2.53M	1.25M	1.62M	596K	820K
Total Stock-Based Compensation	2.53M	1.86M	2.74M	1.47M	1.49M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.29M	10.09K	1.78M	59.75K	1.5M
Short Term Investments	40K	5K	5K	5.15K	533K
Total Cash And Short Term Investments	6.33M	15.09K	1.78M	64.9K	2.03M
Accounts Receivable, Total	-	8.43K	-	81.05K	-
Other Receivables	348K	245K	81.73K	50.39K	130K
Total Receivables	348K	254K	81.73K	131K	130K
Prepaid Expenses	147K	8.16K	46.58K	11.23K	16.99K
Total Current Assets	6.82M	277K	1.91M	208K	2.18M
Goodwill	-	6.41M	-	-	-
Other Intangibles, Total	-	2.52M	-	-	-
Deferred Charges Long-Term	1.58M	-	-	-	-
Total Assets	8.4M	9.2M	1.91M	208K	2.18M
Liabilities
Accounts Payable, Total	459K	1.06M	801K	331K	303K
Unearned Revenue Current, Total	-	23.03K	23.03K	75.19K	38.7K
Total Current Liabilities	459K	1.09M	824K	406K	342K
Total Liabilities	459K	1.09M	824K	406K	342K
Common Stock, Total	11.75M	24.25M	28.82M	30.5M	39.02M
Additional Paid In Capital	1.57M	2.69M	5.26M	5.63M	4.36M
Retained Earnings	-5.38M	-18.82M	-32.99M	-36.33M	-41.55M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	7.94M	8.11M	1.09M	-199K	1.83M
Total Equity	7.94M	8.11M	1.09M	-199K	1.83M
Total Liabilities And Equity	8.4M	9.2M	1.91M	208K	2.18M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40.28M	47.35M	66.34M	74.73M	88.67M
ECS Total Common Shares Outstanding	33.77M	42.52M	65.64M	70.29M	87.38M
Book Value / Share	0.24	0.19	0.02	-0	0.02
Tangible Book Value	7.94M	-810K	1.09M	-199K	1.83M
Tangible Book Value Per Share	0.24	-0.02	0.02	-0	0.02
Total Debt	0	0	0	0	0
Net Debt	-6.33M	-15.09K	-1.78M	-64.9K	-2.03M
Account Code - Inventory Valuation	3	3	3	3	3

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	-5.08M	-13.45M	-14.17M	-3.33M	-5.22M
Amortization of Deferred Charges, Total - (CF)	-	597K	610K	-	-
Asset Writedown & Restructuring Costs	-	5.76M	8.31M	-	-
Stock-Based Compensation (CF)	2.53M	1.86M	2.74M	1.47M	1.49M
Other Operating Activities, Total	-	-248K	-110K	-	-14.27K
Change In Accounts Receivable	-318K	-8.43K	8.43K	-81.05K	81.05K
Change In Accounts Payable	316K	446K	92.83K	-470K	-27.47K
Change in Unearned Revenues	-	23.03K	-	52.16K	-36.49K
Change in Other Net Operating Assets	-1.67M	241K	125K	66.68K	-85.26K
Cash from Operations	-4.23M	-4.78M	-2.39M	-2.29M	-3.81M
Cash Acquisitions	-	-2.07M	-	-	-
Sale (Purchase) of Intangible assets	-	-152K	-	-	-
Investment in Marketable and Equity Securities, Total	-	35K	-	-149	-514K
Cash from Investing	-	-2.19M	-	-149	-514K
Issuance of Common Stock	8.67M	692K	4.16M	573K	5.76M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	8.67M	692K	4.16M	573K	5.76M
Net Change in Cash	4.44M	-6.28M	1.77M	-1.72M	1.44M
Supplemental Items
Levered Free Cash Flow	-673K	-1.46M	-508K	-1.13M	-1.87M
Unlevered Free Cash Flow	-673K	-1.46M	-508K	-1.13M	-1.87M
Change In Net Working Capital	51.99K	-861K	129K	433K	68.17K

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	-60.82	-52.54	-67.17	-204.95	-275.92
Return on Total Capital	-64.56	-57.6	-81.13	-489.3	-402.12
Return On Equity %	-104.08	-167.53	-308.16	-751.33	-638.29
Return on Common Equity	-104.08	-167.53	-308.16	-751.33	-638.29
Margin Analysis
Gross Profit Margin %	-	100	100	100	100
SG&A Margin	-	5.01K	4.5K	730.46	1.13K
EBITDA Margin %	-	-6.02K	-6K	-	-
EBITA Margin %	-	-6.54K	-6.69K	-761.13	-1.22K
EBIT Margin %	-	-6.54K	-6.69K	-761.13	-1.22K
Income From Continuing Operations Margin %	-	-11.9K	-15.87K	-730.45	-1.21K
Net Income Margin %	-	-11.9K	-15.87K	-730.45	-1.21K
Net Avail. For Common Margin %	-	-11.9K	-15.87K	-730.45	-1.21K
Normalized Net Income Margin	-	-4.09K	-4.1K	-456.53	-754.56
Levered Free Cash Flow Margin	-	-1.29K	-568.73	-247.23	-431.72
Unlevered Free Cash Flow Margin	-	-1.29K	-568.73	-247.23	-431.72
Asset Turnover
Asset Turnover	-	0.01	0.02	0.43	0.36
Short Term Liquidity
Current Ratio	14.86	0.25	2.32	0.51	6.36
Quick Ratio	14.54	0.25	2.26	0.48	6.31
Operating Cash Flow to Current Liabilities	-9.21	-4.39	-2.9	-5.64	-11.14
Long Term Solvency
Total Liabilities / Total Assets	5.46	11.82	43.17	195.66	15.72
Net Debt / EBITDA	-	0	0.33	-	-
Net Debt / (EBITDA - Capex)	-	0	0.33	-	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-21.02	410.97	-5.18
Gross Profit, 1 Yr. Growth %	-	-	-21.02	410.97	-5.18
EBITDA, 1 Yr. Growth %	-	-	-26.95	-	-
EBITA, 1 Yr. Growth %	2.03K	46.6	-24.75	-41.84	51.6
EBIT, 1 Yr. Growth %	2.03K	46.6	-24.75	-41.84	51.6
Earnings From Cont. Operations, 1 Yr. Growth %	1.64K	164.49	5.36	-76.49	56.72
Net Income, 1 Yr. Growth %	1.64K	164.49	5.36	-76.49	56.72
Normalized Net Income, 1 Yr. Growth %	1.64K	45.5	-26.14	-43.13	56.72
Diluted EPS Before Extra, 1 Yr. Growth %	229.73	68.06	-16.18	-82.68	34.22
Total Assets, 1 Yr. Growth %	326.63	9.46	-79.24	-89.13	948.69
Tangible Book Value, 1 Yr. Growth %	334.91	-110.2	-233.96	-118.29	-1.02K
Common Equity, 1 Yr. Growth %	334.91	2.1	-86.62	-118.29	-1.02K
Cash From Operations, 1 Yr. Growth %	2.71K	83.51	-49.97	-4.21	66.54
Levered Free Cash Flow, 1 Yr. Growth %	-	-35.16	-71.74	122.12	65.58
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-35.16	-71.74	122.12	65.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	100.88	120.11
Gross Profit, 2 Yr. CAGR %	-	-	-	100.88	120.11
EBITA, 2 Yr. CAGR %	159K	459.04	8.76	-33.84	-6.1
EBIT, 2 Yr. CAGR %	159K	459.04	8.76	-33.84	-6.1
Earnings From Cont. Operations, 2 Yr. CAGR %	159K	578.09	66.94	-50.22	-39.29
Net Income, 2 Yr. CAGR %	159K	578.09	66.94	-50.22	-39.29
Normalized Net Income, 2 Yr. CAGR %	178K	402.94	7.35	-35.19	-5.59
Diluted EPS Before Extra, 2 Yr. CAGR %	-	135.4	20.22	-61.9	-51.78
Accounts Receivable, 2 Yr. CAGR %	-	-	-	210.03	-
Total Assets, 2 Yr. CAGR %	-	116.1	-52.32	-84.98	6.76
Tangible Book Value, 2 Yr. CAGR %	-	-33.39	-63.03	-50.5	30.01
Common Equity, 2 Yr. CAGR %	-	110.72	-63.03	-84.35	30.01
Cash From Operations, 2 Yr. CAGR %	145K	463.68	-4.18	-30.78	26.31
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-52.56	-20.77	91.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-52.56	-20.77	91.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	56.41
Gross Profit, 3 Yr. CAGR %	-	-	-	-	56.41
EBITA, 3 Yr. CAGR %	-	15.37K	193.24	-11.72	-12.78
EBIT, 3 Yr. CAGR %	-	15.37K	193.24	-11.72	-12.78
Earnings From Cont. Operations, 3 Yr. CAGR %	-	18.77K	264.55	-13.14	-27.05
Net Income, 3 Yr. CAGR %	-	18.77K	264.55	-13.14	-27.05
Normalized Net Income, 3 Yr. CAGR %	-	16.56K	171.59	-13.14	-13.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	68.29	-36.97	-42.02
Total Assets, 3 Yr. CAGR %	-	-	-1.02	-70.88	-38.14
Tangible Book Value, 3 Yr. CAGR %	-	-	-15.93	-70.76	31.31
Common Equity, 3 Yr. CAGR %	-	-	-15.93	-70.76	-39.07
Cash From Operations, 3 Yr. CAGR %	-	13.27K	151.43	-4.19	-7.24
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-20.63	1.3
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-20.63	1.3
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	-	1.67K	85.95
EBIT, 5 Yr. CAGR %	-	-	-	1.67K	85.95
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	1.66K	77.97
Net Income, 5 Yr. CAGR %	-	-	-	1.66K	77.97
Normalized Net Income, 5 Yr. CAGR %	-	-	-	1.74K	77.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	2.08
Total Assets, 5 Yr. CAGR %	-	-	-	-	2.02
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	0.09
Common Equity, 5 Yr. CAGR %	-	-	-	-	0.09
Cash From Operations, 5 Yr. CAGR %	-	-	-	1.53K	90.91